🇺🇸 Humulin-N in United States

10,494 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10,494

Most-reported reactions

1. Blood Glucose Increased — 3,994 reports (38.06%)
2. Blood Glucose Decreased — 1,459 reports (13.9%)
3. Drug Ineffective — 1,188 reports (11.32%)
4. Incorrect Dose Administered — 700 reports (6.67%)
5. Maternal Exposure During Pregnancy — 631 reports (6.01%)
6. Visual Impairment — 582 reports (5.55%)
7. Fall — 500 reports (4.76%)
8. Weight Decreased — 489 reports (4.66%)
9. Hypoglycaemia — 486 reports (4.63%)
10. Malaise — 465 reports (4.43%)

Source database →

Frequently asked questions

Is Humulin-N approved in United States?

Humulin-N does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Humulin-N in United States?

Taipei Veterans General Hospital, Taiwan is the originator. The local marketing authorisation holder may differ — check the official source linked above.